homehome Home chatchat Notifications


Billionaire Sean Parker donates $250 million to accelerate breakthrough cancer immunotherapies

A Silicon Valley billionaire who made a fortunate investing in Facebook wants to beat cancer once and for all.

Tibi Puiu
April 13, 2016 @ 4:22 pm

share Share

You might know him as the slick Silicon Valley investor who helped Zuckerberg uproot the most important social network on the planet, but did you know Sean Parker is actually one of the most generous philanthropists in the tech space? His most recent effort involves $250 million of his own money and an unprecedented collaboration between six leading cancer centers. The Parker Institute for Cancer Immunotherapy will focus on the latest breakthroughs in the line of immunotherapy against cancer. The end goal is to beat cancer, once and for good.

Sean Parker

Sean Parker. Credit: Wikimedia Commons

“About half of all cancers, if you catch them early enough are readily treatable with chemotherapy, radiation, and surgery. The other 50% are likely going to kill you,” Parker told Fortune in advance of the announcement. “Immunotherapy is the first breakthrough in recent memory that doesn’t just offer some incremental three to six months average life extension. It offers the possibility to beat cancer.”

The 36-year-old made a multi-billion fortune by launching and investing in various startups, including Napster (remember that?), Facebook (Parker was the first investor) and Spotify among others. He is still active in the tech space, but also in philanthropy having invested over $600 million since 2005 through the Parker Foundation.

Most of the money goes to life sciences, with a focus on cancer research. The newly founded Parker Institute for Cancer Immunotherapy will join leading scientists from the Memorial Sloan Kettering Cancer Center, Stanford Medicine, the University of California, Los Angeles, the University of California, San Francisco, the University of Texas MD Anderson Cancer Center, and the University of Pennsylvania.

Immunotherapy is pretty huge because cancer cells are very good at dodging the immune system’s defence. These therapies use solutions that  improve, target, or restore immune system function thereby stopping or slowing the growth of cancer cells and even helping the immune system destroy the cancer cells. Basically, the Parker Institute for Cancer Immunotherapy will fund the “high risk best ideas that may not get funded by the government,” says Jeffrey Bluestone, a prominent immunologist and former University of California, San Francisco official who now heads the institute.

Infographic by Asian Scientist.

Parker’s beef with current research is that, while survival rates have gone up, these are painfully slow. The five-year survival rate for lung cancer has gone up  from just over 13% to about 17%.since 1995. Now, with so much funding and a dedicated team focused on improving sharing and collaborative progress between the involved parties, scientists are free to make some real breakthroughs.

“My belief, my sincere belief, is that this is very early days for cancer immunotherapy, and that most of the breakthroughs are still to come,” said Parker. “We have a proof of concept that this works in certain cancers, and now the hard work of expanding immunotherapy to many cancers begins.”

Hats off to Mr. Parker.We need more generous people like him or Tej Kohli, who can funnel some of their vast wealth towards making the world a better place.

share Share

A Brain Implant Just Turned a Woman’s Thoughts Into Speech in Near Real Time

This tech restores speech in real time for people who can’t talk, using only brain signals.

Using screens in bed increases insomnia risk by 59% — but social media isn’t the worst offender

Forget blue light, the real reason screens disrupt sleep may be simpler than experts thought.

We Should Start Worrying About Space Piracy. Here's Why This Could be A Big Deal

“We are arguing that it’s already started," say experts.

An Experimental Drug Just Slashed Genetic Heart Risk by 94%

One in 10 people carry this genetic heart risk. There's never been a treatment — until now.

We’re Getting Very Close to a Birth Control Pill for Men

Scientists may have just cracked the code for male birth control.

A New Antibiotic Was Hiding in Backyard Dirt and It Might Save Millions

A new antibiotic works when others fail.

Researchers Wake Up Algae That Went Dormant Before the First Pyramids

Scientists have revived 7,000-year-old algae from Baltic Sea sediments, pushing the limits of resurrection ecology.

A Fossil So Strange Scientists Think It’s From a Completely New Form of Life

This towering mystery fossil baffled scientists for 180 Years and it just got weirder.

ChatGPT Seems To Be Shifting to the Right. What Does That Even Mean?

ChatGPT doesn't have any political agenda but some unknown factor is causing a subtle shift in its responses.

This Freshwater Fish Can Live Over 120 Years and Shows No Signs of Aging. But It Has a Problem

An ancient freshwater species may be quietly facing a silent collapse.